INDV 8-K 2026-10-06

Indivior Pharmaceuticals, Inc. (INDV) 8-K dated 2026-10-06 — accession 0001104659-26-113883. This URL is the filing, not the INDV hub.

Indivior Pharmaceuticals, Inc. (INDV) is a drug manufacturers - specialty & generic company listed on NASDAQ.

Indivior Pharmaceuticals, Inc. filed a 8-K on 2026-10-06. Accession 0001104659-26-113883.

Cached items: 8.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported INDV revenue for 2025-12-31 was $1.24B. Net income was $210.0M. Revenue was up 4.3% from 2024-12-31 to 2025-12-31. INDV currently screens at market cap $4.48B and trailing P/E 12.5.

Not investment advice. The INDV SEC hub lists recent forms. The stock page is the research view.